Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vegetarian diets and esophageal cancer risk.

British journal of cancer·2026
Same author

PSA Screening and Prostate Cancer Mortality.

JAMA·2024
Same author

Inflammation, infection, and cardiovascular risk.

Lancet (London, England)·2024
Same author

Bempedoic Acid for Primary Prevention of Cardiovascular Events.

JAMA·2023
Same author

Identifying those at risk for COVID-19 related suicide. Response to "Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?"

Neuroscience and biobehavioral reviews·2022
Same author

The Increasing Incidence of Early-Onset Colorectal Cancer.

The New England journal of medicine·2022

Related Experiment Video

Updated: Jul 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Questioning the "beatification" of statins.

Luca Mascitelli, Francesca Pezzetta

    International Journal of Cardiology
    |February 27, 2007
    PubMed
    Summary

    Statins may not be miracle drugs for heart health. Lifestyle changes are crucial for cardiovascular prevention, as statins haven't significantly altered mortality trends and may encourage unhealthy habits.

    Area of Science:

    • Cardiovascular Medicine
    • Pharmacology
    • Public Health

    Background:

    • Statins are widely promoted for cardiovascular prevention, but their impact on coronary heart disease mortality trends since their US approval is questionable.
    • Obesity rates have risen significantly during the same period, raising concerns about potential lifestyle deterioration due to perceived drug-induced protection.

    Discussion:

    • The cornerstone of cardiovascular prevention remains lifestyle modification, yet statin trials have not compared drugs against non-atherogenic lifestyles.
    • Evidence for a total mortality benefit in women and the elderly from dyslipidemia therapy is lacking.
    • Statin side effects, often downplayed as relative risks, may be more prevalent in clinical practice than in randomized trials.

    Key Insights:

    • Healthful lifestyle adherence is linked to reduced rates of coronary disease, diabetes in women, and mortality in the elderly.

    Related Experiment Videos

    Last Updated: Jul 16, 2026

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
    09:15

    Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

    Published on: November 10, 2017

  • Statin therapy's potential contribution to lifestyle deterioration and its long-term effects, including cancerogenesis, require further investigation.
  • Commercial sponsorship may bias the reporting of statin trial findings, potentially minimizing harm.

    • Outlook:

    • Future research should prioritize head-to-head comparisons of statins with lifestyle interventions.
    • There is a need for transparent reporting of statin trial outcomes, including absolute risks and potential harms.
    • A balanced approach integrating lifestyle changes with judicious statin use is essential for effective cardiovascular disease management.